Preparation method of quality control serum for ischemia-modified albumin
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A protein and quality control product technology, applied in the field of preparation of ischemia-modified albumin control products, can solve problems such as difficulty in separation and purification, and achieve the effects of simple preparation process, low production cost and good uniformity
Active Publication Date: 2012-07-04
NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD
View PDF4 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Due to the particularity of the nitrogen-terminal sequence of HSA, the possibility of obtaining human IMA from other animals is ruled out, and because the difference between IMA and HSA is very small, there may be only 2-4 amino acid differences, so it is also very difficult to separate and purify it from HSA. difficulty
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0025] (1) Collect 100 ml of serum from healthy people who have excluded infectious diseases and common diseases, and use it as a serum raw material to adjust the pH value to 7.2;
[0026] (2) Add 9.2 mM FeSO 4 and 39 mM hydrogen peroxide;
[0027] (3) Reaction under UV light irradiation at 37°C for 20 min;
[0028] (4) Dialyze in 10 mM Tris-HCl buffer at 25°C, pH 7.5, for 12 h;
[0029] (5) Add 0.1 ml of 4-chloro-3,5-dimethylphenol, mix evenly, and divide into glass bottles. The volume of each bottle is 1 ml, and the ELISA kit is used to determine its value.
Embodiment 2
[0031] (1) Collect 100 ml of serum from healthy people who have excluded infectious diseases and common diseases, and use it as a serum raw material to adjust the pH value to 7.5;
[0032] (2) Add 1 mM iron porphyrin and 10 mM hydrogen peroxide;
[0033] (3) React at 37°C for 30 minutes under visible light mercury lamp irradiation;
[0034] (4) Dialyze in 25°C, pH 8.0, 100 mM disodium hydrogen phosphate-citrate buffer for 24 h;
[0035] (5) Add 0.1 g NaN 3 , mixed evenly, and distributed in glass bottles, the volume of each bottle was 1 ml, and the ELISA kit was used to determine its value.
Embodiment 3
[0037] (1) Collect 100 ml of serum from healthy people who have excluded infectious diseases and common diseases, and use it as a serum raw material to adjust the pH value to 7.0;
[0038] (2) Add 0.5 mM CuSO 4 and 50 mM hydrogen peroxide;
[0039] (3) React for 15 minutes under visible light mercury lamp irradiation at 37°C;
[0040] (4) Dialyze in 100 mM imidazole buffer at 25°C, pH 7.8, for 18 h;
[0041] (5) Add 0.1 ml of 4-chloro-3,5-dimethylphenol, mix evenly, and divide into glass bottles. The volume of each bottle is 1 ml, and the ELISA kit is used to determine its value.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a preparation method of quality control serum for ischemia-modified albumin; the preparation method comprises the following steps of: (1) adopting the blood serum of a healthy person, and adjusting a pH value to be 7.0-7.5; (2) adding 0.1-100mm of metal ionic salt with a variable valence center or a metal organic composite with molecule planarity to the blood serum, and then adding 0.1-100mm of hydrogen peroxide; (3) reacting for 10-30min under the 35-40 DEG C illumination; (4) dialyzing a solution obtained through the reaction in the step (3) in 0.1-1000mm of a dialysis buffer solution with pH of 7.5-8.0 under the 20-25 DEG C temperature for 12-24h; and (5) adding a preservative according to a conventional technology, subpackaging and determining after mixing uniformly. The preparation method has the advantages of adequate the source of raw materials, easily obtaining of the raw materials, simple preparation technology, few amount of additives, low production cost, small non-specificity interference, no needing for composite dissolving, good homogeneity and small difference between bottles.
Description
technical field [0001] The invention relates to a preparation method of an ischemic modified albumin control product. Background technique [0002] Acute coronary syndrome (ACS) has different clinical manifestations, but they all have the same pathophysiological process, that is, atherosclerotic plaque shedding, platelet aggregation and thrombus formation, leading to coronary artery stenosis and blockage. And cause myocardial ischemia, if the myocardial ischemia time is prolonged, it will lead to myocardial cell necrosis and myocardial injury. Therefore, identification of myocardial ischemia before myocardial necrosis, early diagnosis and initiation of treatment are crucial for patients. At present, the diagnosis of cardiac ischemia mostly relies on the changes of the ST segment and T wave of the electrocardiogram, which is the easiest, fastest and cheapest examination method for myocardial ischemia, but patients with myocardial infarction may also show no abnormalities in ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more